Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 35.20%959.74M | 8.99%719.93M | 11.05%668.28M | 6.46%2.66B | 4.72%687.7M | 3.23%709.86M | 5.32%660.58M | 14.22%601.77M | 21.32%2.5B | 20.85%656.68M |
| Operating revenue | 35.20%959.74M | 8.99%719.93M | 11.05%668.28M | 6.46%2.66B | 4.72%687.7M | 3.23%709.86M | 5.32%660.58M | 14.22%601.77M | 21.32%2.5B | 20.85%656.68M |
| Cost of revenue | 38.69%710.81M | 7.11%535.57M | 9.00%521.52M | 5.16%2B | 2.61%511.14M | -0.28%512.52M | 6.46%500.03M | 13.35%478.47M | 21.42%1.9B | 20.31%498.16M |
| Gross profit | 26.15%248.93M | 14.83%184.36M | 19.02%146.76M | 10.64%657.74M | 11.38%176.55M | 13.61%197.33M | 1.91%160.55M | 17.74%123.3M | 20.99%594.49M | 22.61%158.52M |
| Operating expense | 43.39%121.79M | 17.69%94.85M | 20.66%99.94M | 11.58%340.09M | 6.73%91.73M | 11.39%84.94M | 8.10%80.59M | 21.73%82.83M | 19.71%304.79M | 28.01%85.95M |
| Selling and administrative expenses | 43.39%121.79M | 17.69%94.85M | 20.66%99.94M | 11.58%340.09M | 6.73%91.73M | 11.39%84.94M | 8.10%80.59M | 21.73%82.83M | 19.71%304.79M | 28.01%85.95M |
| -General and administrative expense | 43.39%121.79M | 17.69%94.85M | 20.66%99.94M | 11.58%340.09M | 6.73%91.73M | 11.39%84.94M | 8.10%80.59M | 21.73%82.83M | 19.71%304.79M | 28.01%85.95M |
| Operating profit | 13.12%127.14M | 11.95%89.51M | 15.66%46.82M | 9.65%317.65M | 16.88%84.82M | 15.34%112.39M | -3.66%79.96M | 10.34%40.48M | 22.37%289.7M | 16.77%72.57M |
| Net non-operating interest income (expenses) | 6.96%-33.75M | 4.79%-32.14M | -2.83%-32.7M | -15.09%-137.86M | -15.36%-36.04M | -15.73%-36.27M | -12.89%-33.75M | -16.44%-31.8M | -52.75%-119.79M | -29.21%-31.24M |
| Non-operating interest expense | -6.96%33.75M | -4.79%32.14M | 2.83%32.7M | 15.09%137.86M | 15.36%36.04M | 15.73%36.27M | 12.89%33.75M | 16.44%31.8M | 52.75%119.79M | 29.21%31.24M |
| Other net income (expenses) | -49.71%-2.32M | -119.45%-2.73M | -104.90%-2.67M | -73.13%-11.8M | -255.12%-7.71M | 5.03%-1.55M | 52.21%-1.24M | -215.22%-1.31M | 0.42%-6.82M | -244.44%-2.17M |
| Special income (charges) | -49.71%-2.32M | -119.45%-2.73M | -104.90%-2.67M | -73.13%-11.8M | -255.12%-7.71M | 5.03%-1.55M | 52.21%-1.24M | -215.22%-1.31M | 0.42%-6.82M | -244.44%-2.17M |
| -Less:Restructuring and mergern&acquisition | 49.71%2.32M | 119.45%2.73M | 104.90%2.67M | 73.13%11.8M | 255.12%7.71M | -5.03%1.55M | -52.21%1.24M | 215.22%1.31M | -0.42%6.82M | 244.44%2.17M |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --951K | --0 |
| Income before tax | 22.12%91.07M | 21.54%54.64M | 55.20%11.44M | 3.00%167.98M | 4.88%41.08M | 15.66%74.58M | -10.96%44.96M | -17.72%7.37M | 7.67%163.09M | 4.88%39.16M |
| Income tax | 19.50%22.34M | 18.85%14.63M | 48.89%4.24M | 14.62%46.75M | 27.29%12.9M | 24.99%18.69M | -9.45%12.31M | 35.48%2.85M | -2.43%40.79M | -2.07%10.14M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 23.00%68.74M | 22.55%40.01M | 59.17%7.21M | -0.88%121.24M | -2.94%28.17M | 12.85%55.89M | -11.51%32.65M | -34.00%4.53M | 11.52%122.31M | 7.55%29.03M |
| Net income continuous operations | 23.00%68.74M | 22.55%40.01M | 59.17%7.21M | -0.88%121.24M | -2.94%28.17M | 12.85%55.89M | -11.51%32.65M | -34.00%4.53M | 11.52%122.31M | 7.55%29.03M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 23.00%68.74M | 22.55%40.01M | 59.17%7.21M | -0.88%121.24M | -2.94%28.17M | 12.85%55.89M | -11.51%32.65M | -34.00%4.53M | 11.52%122.31M | 7.55%29.03M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 23.00%68.74M | 22.55%40.01M | 59.17%7.21M | -0.88%121.24M | -2.94%28.17M | 12.85%55.89M | -11.51%32.65M | -34.00%4.53M | 11.52%122.31M | 7.55%29.03M |
| Diluted earnings per share | 11.86%1.32 | 13.04%0.78 | 40.00%0.14 | -6.25%2.55 | -4.92%0.58 | 11.32%1.18 | -18.82%0.69 | -37.50%0.1 | 0.00%2.72 | -3.17%0.61 |
| Basic earnings per share | 14.81%1.24 | 11.94%0.75 | 55.56%0.14 | -6.04%2.49 | -4.92%0.58 | 9.09%1.08 | -16.25%0.67 | -43.75%0.09 | 0.38%2.65 | -1.61%0.61 |
| Dividend per share | 0.00%0.66 | 0.00%0.66 | 0.00%0.66 | 3.94%2.64 | 1.54%0.66 | 4.76%0.66 | 4.76%0.66 | 4.76%0.66 | 5.39%2.54 | 3.17%0.65 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.